- IRRAS will exhibit at the upcoming
Congress of Neurological Surgeons (CNS) annual meeting inSan Francisco, CA , fromOctober 8 - 12, 2022 , and theNeurocritical Care Society (NCS) annual meeting inSan Antonio, TX , onOctober 17 - 21, 2022 . - IRRAS will participate in the "Neurotrauma Across the Lifespan and Around the World" symposium at CNS on
Sunday, October 9, 2022 , beginning at0800 PDT , which will provide hands-on product training to symposium attendees. - During CNS, Dr.
Behnam Rezai Jahromi , a neurosurgeon fromHelsinki University Hospital , will present a scientific poster titled "Active Cerebrospinal Fluid (CSF) Exchange and Removal of Subarachnoid Hemorrhage (SAH) to Reduce Shunt Dependency."
Both meetings are well-respected and highly engaging conferences that bring together neurosurgeons, neurointensivists, and other healthcare professionals from around the world to enhance health and improve lives through the advancement of neurosurgical education and scientific exchange.
During CNS, IRRAS will exhibit at booth #332, and, at NCS, IRRAS' team will be available at booth #513 to meet with attendees and provide demonstrations of the IRRAflow and Hummingbird neuromonitoring product lines. Attendees at both conferences are encouraged to visit the IRRAS booths to learn more.
Also at CNS, IRRAS will participate in an all-day symposium where international experts will present their unique perspectives on neurotrauma management to integrate best practices and emerging evidence to optimize outcomes. The symposium will include a product demonstration station, where IRRAflow, the world's first active fluid exchange system, and the Hummingbird ICP advanced neuromonitoring product line will be showcased. Details are provided below.
Symposium Details
Title: "SYM11: Neurotrauma Across the Lifespan and Around the World"
Date:
Time:
Location: Moscone Center,
In addition to the neurotrauma symposium participation at CNS, clinical data regarding the use of the IRRAflow system will also be presented. Dr.
"October will be an exciting month for IRRAS, and we are excited for the opportunity to partner with the
About IRRAS
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in
IRRAS maintains its headquarters in
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
Director, Investor Relations
sten.gustafsson@irras.com
+46 102 11 5172
The information was released for public disclosure, through the agency of the contact person above, on
https://news.cision.com/irras/r/irras-announces-participation-and-educational-symposium-at-key-upcoming-neurosurgery-conferences,c3642706
(c) 2022 Cision. All rights reserved., source